Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is ...

Johnson & Johnson's (J&J) human neonatal Fc receptor (FcRn)-blocking monoclonal antibody Imaavy (nipocalimab-aahu) has ...

For details, see the “Before receiving Ultomiris” section. With myasthenia gravis, dysfunctional muscle ... begins with a loading dose. Two weeks after the loading dose, you’ll continue ...

While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia gravis, the New ...

Changes in intravenous or subcutaneous immunoglobulin usage before and after efgartigimod initiation in patients with myasthenia gravis. Poster presented at: AMCP 2025; March 31-April 3 ...

MG-ADL (Myasthenia Gravis-Activities of Daily Living ... reactions may happen during or up to a few weeks after your IMAAVY™ infusion. Get emergency medical help right away if you get any ...

As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...

Patients are able to self-inject after proper instruction in subcutaneous ... President and CEO of the Myasthenia Gravis Foundation of America. “The daily burden of CIDP from both the symptoms ...